The primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.
Medical Management
A comprehensive evaluation is required for both the living donor and the recipient to identify and mitigate any potential complications. Compatibility tests, including blood typing, tissue typing, and antibody screening, are performed to assess immunological compatibility. To minimize postoperative infection risk, both the donor and recipient must be free of active infections before surgery.
Psychosocial Assessments
Psychosocial assessments play a crucial role in preoperative management. For recipients, these evaluations help identify coping mechanisms, social support, financial readiness, and psychiatric history, as immunosuppressive therapy, including corticosteroids, can worsen pre-existing mental health conditions. Donors also undergo psychosocial evaluations to confirm informed consent, autonomy, and psychological readiness, ensuring they are well-prepared and free from coercion.
For living donors, a laparoscopic nephrectomy is typically performed, which is minimally invasive and reduces blood loss, postoperative pain, recovery time, and hospital stay. During nephrectomy, the kidney is carefully removed, flushed with a chilled, sterile electrolyte solution, and prepared for transplantation. In rare cases, an open nephrectomy may be required, necessitating a lateral positioning and an incision near the eleventh rib for optimal kidney access.
For the recipient, the donated kidney is placed extraperitoneally in the iliac fossa, typically on the right side, to facilitate surgical access and reduce potential complications. Rapid revascularization is essential to minimize ischemic injury, so the donor’s renal artery and vein are anastomosed to the recipient’s internal or external iliac artery and external iliac vein, respectively. Once blood flow is restored, the transplanted kidney should regain a healthy pink color and firm texture and often begin producing urine almost immediately. The ureter is connected to the recipient’s bladder using ureteroneocystostomy, where it is tunneled into the bladder submucosa to minimize infection risk. A urinary catheter containing an antibiotic solution is often used to distend the bladder and support healing during the early postoperative phase. Typically, the procedure lasts between 3 and 4 hours.
Rejection of the transplanted kidney may occur at various stages post-transplant. Hyperacute rejection happens within 24 hours due to an immediate antibody-mediated response, often requiring kidney removal. Acute rejection arises within days to weeks and may manifest as elevated serum creatinine, fever, tenderness, malaise, and oliguria. It is managed with prompt immunosuppressive therapy, including agents such as tacrolimus, corticosteroids, or belatacept.
Medication Management
To prevent gastrointestinal complications associated with corticosteroid use, prophylactic medications such as H2-blockers such as famotidine or PPIs like omeprazole are prescribed. Since immunosuppressive regimens heighten the risk of infections, including gastrointestinal and urinary tract fungal infections, prophylactic antifungal therapy may be administered when clinically indicated.
Preoperative management for kidney transplantation involves optimizing the recipient's metabolic state through diet, dialysis, and infection control.
Both the donor and recipient undergo comprehensive assessments, including blood typing, tissue typing, antibody screening for compatibility, and psychological evaluations.
Laparoscopic nephrectomy is usually performed on living donors to reduce blood loss, pain, and recovery time. Rarely an open nephrectomy with a lateral incision near the eleventh rib is performed.
In the recipient, the kidney is positioned extraperitoneally in the right and left iliac fossa for access, with the donor's renal artery and vein connected to the recipient's iliac vessels.
Once blood flow resumes, the kidney should turn pink and may produce urine immediately.
Postoperative transplant rejection includes hyperacute rejection within 24 hours, potentially requiring kidney removal, and acute rejection within 3–14 days, marked by elevated creatinine, fever, and tenderness, managed with immunosuppressants like tacrolimus.
H2-blockers or PPIs are used prophylactically to prevent corticosteroid-induced gastrointestinal complications.
繁體中文
